Prime Highlights
- Patients with the Pn2 pattern came off ventilators fastest, recovering notably quicker than those with the Pn3 pattern.
- Researchers believe identifying a patient’s pattern early could guide more precise treatment, cutting deaths, shortening ICU stays and reducing unnecessary antibiotic use.
Key Facts
- Cambridge researchers found three distinct lung inflammation patterns, called “Pneumotypes,” among patients with suspected severe pneumonia.
- These patterns showed up clearly in lung fluid but barely registered in blood tests.
Background
Doctors treating severe pneumonia may be missing something important by focusing only on blood tests, a new Cambridge study suggests.
Researchers looked at lung fluid and blood samples from 95 critically ill patients on ventilators. Out of these, 80 patients had enough usable data for the team to sort them into three groups based on gene activity inside their lungs. They called these groups Pneumotypes.
Each group told a different story. Patients in one group had lung injury without much inflammation. Another group showed stronger immune activity and signs of active inflammation. The third group struck more of a balance, with faster tissue repair, and these patients tended to leave the ventilator sooner than the rest.
Here’s the twist: blood tests couldn’t tell these groups apart. The differences lived almost entirely in the lungs, not the bloodstream, which means relying on blood alone could give doctors an incomplete picture.
Dr Andrew Conway Morris, who led the study, said the field needs to shift its thinking. Rather than just diagnosing pneumonia broadly, he said, doctors should ask what specific inflammatory pattern is playing out in a patient’s lungs.
Fellow researcher Dr Vilas Navapurkar said pinpointing that pattern early could let doctors tailor treatment to each patient, easing symptoms faster, shortening hospital stays, and avoiding antibiotics that may not even be needed.
